Elisabeth A. Sandoval is on the board of PROCEPT BioRobotics Corp., Satsuma Pharmaceuticals, Inc. and VYNE Therapeutics, Inc. In her past career Ms. Sandoval was Chief Commercial Officer at Kythera Biopharmaceuticals LLC, Chief Commercial Officer & EVP-Corporate Strategy at Lundbeck Seattle BioPharmaceuticals, Inc., Vice President-Global Marketing at Allergan Ltd. (Ireland) and Vice President-Global Marketing at Bausch & Lomb BV.

She received an MBA from Pepperdine University and an undergraduate degree from the University of California, Irvine.